NEW YORK (GenomeWeb News) – The US Federal Trade Commission today said that Thermo Fisher Scientific has agreed to sell certain assets to GE Healthcare as a condition of getting clearance for its acquisition of Life Technologies.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.
George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.
A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.
The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.